Drug Royalty Corporation

Drug Royalty Corporation is a private investment management company. The company deploys its capital by acquiring existing royalty streams or revenue interests in life science industry products from inventors, academic and research institutions, or companies. Focused on the healthcare industry, the company manages over one billion US dollars.